Vision & Eye Health Research Discussion

⏳ Longevity Research Protocol

Back to Library

Longevity Research

Vision & Eye Health Research Discussion

Educational protocol for compounds being studied in retinal health, mitochondrial function in ocular tissue, and age-related vision research

High Risk ProfileadvancedLow Evidence
Research Information

This protocol is provided for educational and informational purposes only. It does not constitute medical advice, a diagnosis, a treatment plan, or a prescription.

All dose ranges, frequencies, durations, and compound selections must be determined by a licensed healthcare professional based on your individual medical history, lab results, and clinical assessment.

Lab monitoring may be required depending on the compound(s), individual health status, and duration of use. Discuss appropriate monitoring protocols with your clinician.

Do not use any peptide compound if you are pregnant, breastfeeding, a minor, or have uncontrolled medical conditions without explicit direction from your physician.

High Risk — Specialist Supervision Required

Significant safety considerations; not suitable for unsupervised use

Overview

This educational protocol covers research discussion points for peptide compounds being studied in the context of retinal health, mitochondrial function in ocular tissue, and age-related vision research. This is a HIGH RISK designation given the experimental nature of ocular applications for these compounds and the absence of human clinical trial data in eye health contexts. An ophthalmologist or retinal specialist must be involved in any clinical consideration.

Mechanism Summary

Humanin, a mitochondrial-derived peptide, has been studied for cytoprotective effects on retinal ganglion cells and photoreceptors in models of retinal degeneration; it signals through a tripartite receptor complex (CNTFR, IL-6Rβ, gp130) and inhibits apoptosis. MOTS-c, also mitochondrial-derived, regulates AMPK-mediated metabolic pathways; the retina is highly metabolically active and mitochondria-dependent, making mitochondrial health directly relevant to ocular function research. Epitalon (Ala-Glu-Asp-Gly) is a synthetic pineal tetrapeptide studied for telomerase induction and anti-aging effects, with some animal research examining its effects on retinal function and age-related ocular changes.

Intended Goal

Prepare for a clinician consultation on peptide compounds studied in retinal health, mitochondrial ocular function, and age-related vision research contexts

Mitochondrial-derived peptide / retinal / neuroprotective

Studied for retinal ganglion cell cytoprotection and potential applications in age-related macular degeneration research. Catalog reference.

Mitochondrial-derived peptide / metabolic / ocular metabolism

Studied for mitochondrial metabolic regulation with emerging research interest in ocular metabolic health contexts. Catalog reference.

Telomerase activator / anti-aging / pineal peptide

Synthetic tetrapeptide studied for telomerase activation and anti-aging properties, with some research interest in age-related retinal and tissue contexts. Catalog reference.

Protocol calculator: All compounds shown together. Set each vial size, BAC water added, and your intended dose — the draw units update instantly for every peptide in this protocol. Defaults are placeholders — adjust to your actual vials and clinician instructions.
HumaninMitochondrial-derived peptide / retinal / neuroprotective
Draw
10
units
Conc
2500
mcg/mL
Vol
0.1
mL
Doses/vial
20
inj.
MOTS-cMitochondrial-derived peptide / metabolic / ocular metabolism
Draw
10
units
Conc
2500
mcg/mL
Vol
0.1
mL
Doses/vial
20
inj.
EpitalonTelomerase activator / anti-aging / pineal peptide
Draw
10
units
Conc
2500
mcg/mL
Vol
0.1
mL
Doses/vial
20
inj.

Research reference values only. Confirm all parameters with current literature and your clinician.

Who may be a candidate

  • Adults with clinician-confirmed age-related macular degeneration or retinal conditions under ophthalmology care
  • Individuals working with longevity clinicians who include ocular health in their assessments
  • Those with a family history of retinal degeneration seeking research discussion frameworks

Exclusions

  • Not appropriate without ophthalmology or retinal specialist involvement
  • Not appropriate for acute vision emergencies — seek immediate ophthalmology care
  • Not a replacement for evidence-based retinal treatments (anti-VEGF injections, laser therapy)
1

Are there any peptide compounds with human evidence in retinal health that I should know about?

2

How do you incorporate mitochondrial health assessment into your longevity or ophthalmology practice?

3

What is your view on Epitalon for anti-aging applications given the current evidence base?

4

How would you monitor for ocular changes during any research compound program?

5

What evidence-based interventions would you prioritise for my retinal health before considering research compounds?

Print or copy these questions using the "Copy Summary" button to bring to your appointment.

Legal & Compliance Notice

Humanin, MOTS-c, and Epitalon are research compounds not approved for any therapeutic use. Verify all regulatory statuses with a licensed ophthalmologist and clinician.

The legal and regulatory status of research compounds varies by country and jurisdiction. It is the user's responsibility to understand applicable local laws before engaging with any compound.

This application does not provide personalized dosing recommendations. Users who require medical guidance should consult a qualified clinician.

Last reviewed: 2025-03-01 · Status: reviewed

Discuss with Your Clinician

Use this protocol as a research starting point. A qualified healthcare professional can review your health history, order appropriate labs, and help you determine what approach — if any — makes sense for your specific situation.

Bring this protocol to your appointmentUse the questions below as a discussion guide